Azintuxizumab vedotin, CAS 1826819-58-2

Product Description: Azintuxizumab vedotin (ABBV-838) is an antibody–drug conjugate (ADC) targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Vij R, et al. First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clin Cancer Res. 2020 May 15;26(10):2308-2317.

CAS Number: 1826819-58-2

Molecular Weight: N/A

Compound Purity: 98.55

Research Area: Cancer

Solubility: H2O

Target: Antibody-Drug Conjugates (ADCs)

• SKU: MEXHY-P99454-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99454-10
• Package Unit: 10 mg
• Quantity Unit: STK